Antidepressant-induced bruxism: Need for buspirone? [1]

International Journal of Neuropsychopharmacology

Volumn 9, Issue 4, 2006, Pages 485-487

  Ranjan, Sanjeev ^a   S Chandra, Prabha ^a   Prabhu, Santosh ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BUSPIRONE; CITALOPRAM; ESCITALOPRAM; LOSARTAN; SEROTONIN 1A AGONIST; SEROTONIN UPTAKE INHIBITOR; VENLAFAXINE;

ADULT; BRUXISM; CASE REPORT; DEPRESSION; DOSE TIME EFFECT RELATION; DRUG DOSE REDUCTION; DRUG INDUCED DISEASE; DRUG MECHANISM; DRUG WITHDRAWAL; FEMALE; HUMAN; LETTER; MALE; PRIORITY JOURNAL;

ADOLESCENT; ANTIDEPRESSIVE AGENTS; BRUXISM; BUSPIRONE; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 33745583839     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145705005985     Document Type: Letter

References (8)

1. Bostwick JM, Jaffee MS (1999). Buspirone as an antidote to SSRI-induced bruxism. Journal of Clinical Psychiatry 60, 857-860.
2. Ellison JM, Stanziani P (1993). SSRI associated nocturnal bruxism in four patients. Journal of Clinical Psychiatry 54, 432-434.
3. Jaffee MS, Bostwick JM (2000). Buspirone as an antidote to venlafaxine induced bruxism. Psychosomatics 41, 535-536.
4. Moore CA, Williams RL, Hirshkowitz M (2000). Sleep disorders. In: Sadock BJ, Sadock VA (Eds.), Kaplan & Sadock's Comprehensive Text Book of Psychiatry, vol. 2 (7th edn) (pp. 1677-1700). Philadelphia: Lippincott Williams & Wilkins.
5. Pavlovic ZM (2004). Buspirone to improve compliance in venlafaxine-induced movement disorder. International Journal of Neuropsychopharmacology 7, 523-524.
6. Richelson E (2002). The pharmacological relevance of antidepressant interaction with neurotransmitter transporters and receptors. Psychopharmacology Bulletin 36, 133-150.
7. Stahl SM (1997). Psychopharmacology of Antidepressants. London: Martin Dunitz.
8. Wise MEJ (2001). Citalopram induced bruxism. British Journal of Psychiatry 178, 182.